Kestra Advisory Services, LLC Annexon, Inc. Transaction History

Kestra Advisory Services, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.63 - $4.63 $17,930 - $50,930	-11,000 Reduced 52.38%	10,000 $45,000
Q3 2023 Nov 09, 2023	SELL	$2.13 - $3.84 $8,520 - $15,360	-4,000 Reduced 16.0%	21,000 $49,000
Q2 2023 Aug 11, 2023	BUY	$2.1 - $6.37 $21,000 - $63,700	10,000 Added 66.67%	25,000 $88,000
Q1 2022 Apr 26, 2022	BUY	$2.73 - $11.94 $40,950 - $179,100	15,000 New	15,000 $40,000

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $245M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Kestra Advisory Services, LLC with notifications on news.